介入心脏病学 第8版

介入心脏病学 第8版
作 者: 埃里克 J托波尔 保罗 泰尔斯坦(PaulS Teirs
出版社: 科学技术文献出版社
丛编项:
版权说明: 本书为公共版权或经版权方授权,请支持正版图书
标 签: 暂缺
ISBN 出版时间 包装 开本 页数 字数
未知 暂无 暂无 未知 0 暂无

作者简介

暂缺《介入心脏病学 第8版》作者简介

内容简介

Textbook of Interventional Cardiology(8th Edition)的修订是本系列丛书出版以来大的一次更新。本书充分涵盖近期介入心脏病学领域令人激动的进展,并强调严格的循证方法。本次修订新增的内容涉及冠状动脉微血管疾病的诊断和治疗、经皮三尖瓣修复和瓣中瓣介入。多年来,随着心脏支架技术的逐步成熟和药物治疗的进展,冠状动脉介入治疗的预后情况变得越来越可预测,而且在许多方面成为常规诊疗手段。在某些方面,介入心脏病学领域失去了一些开创性的火花,而这些火花从 20世纪 80年代开始就成为本学科突出的特点。在那个激动人心的时代,在冠状动脉中行球囊血管成形术的结果往往是难以预测的,支架内血栓的风险相比如今也是难以预料的。介入心脏病学专家和科学家不仅要应对独特个案病例的挑战,而且要发现重要的创新,使该专业的突出地位和重要性得以延续。如今,这些挑战仍在继续,但已今非昔比。接受冠状动脉介入治疗患者的复杂程度急剧增加,包括高龄、左主干病变、慢性闭塞病变,以及病情复杂到令医师望而却步的患者。 A型病变的患者到底发生过什么?经皮冠状动脉介入治疗在高 SYNTAX积分的患者中应该怎样开展?同时,医疗经济方面的要求也给介入心脏学专家带来了更多的负担,包括时间、设备选择上的限制,以及履行对急性心肌梗死等紧急情况的全天候保障责任。此外,还有来自记分制措施和对手术适当性或过度使用的考核压力。但希望这些挑战都能被帮助有症状、生活质量受限的患者康复带来的巨大满足感所抵消。在医学界,这种感觉普遍的莫过于经导管主动脉瓣置换术这一重大变革性领域。本书旨在为介入心脏病学领域人士提供参考资料,其中不仅包括执业心脏病专家,还包括参与手术的团队、转诊医师,以及那些正在接受培训或有志于培训的人员。我们为许多章节邀请了新的作者,以提供一种全新的感受与视角,每一章的作者都是本领域中被广泛认可的专家学者。展望未来,我们充分认识到需要加强与心脏外科医师的合作——将介入与外科手术擅长的方面进行交叉融合,在通力合作下使得心脏瓣膜手术日益普及,使更多患者受益。我们想对来自世界各地的作者表示真诚和深切的感谢,他们为本书做出了巨大的贡献。他们共同组成了一个杰出的智囊团,我们在审核本书内容时从他们那里学到了很多。感谢 Elsevier的 Mary Hegeler对这项工作的专业支持,尤其特别感谢心血管读者群体, 30多年来他们一直支持本系列书使之成...

图书目录

SECTION I Patient Selection, 1

1 Individualized Assessment for Percutaneous or

Surgical-Based Revascularization, 5

Vasim Farooq, Rodrigo Modolo, and Patrick W. Serruys

2 Evidence-Based Interventional Practice, 43

Franz-Josef Neumann, Miroslaw Ferenc, and Kambis Mashayekhi

3 Diabetes, 65

Marco Roffi and Baris Gencer

4 Noninvasive Evaluation: Functional Testing,

Multidetector Computed Tomography, and Stress

Cardiac MRI, 81

Vikram M. Brahmanandam and Mario J. Garcia

5 Intracoronary Pressure and Flow Measure-ments, 103

Morton J. Kern, Michael J. Lim, and Katherine Yu

6 Contrast-Induced Acute Kidney Injury and the Role of Chronic Kidney Disease in Percutaneous CoronaryIntervention, 133

Roxana Mehran, Birgit Vogel, and Sabato Sorrentino

7 Radiation Safety During Cardiovascular

Procedures, 145

Beth A. Schueler, Kenneth A. Fetterly, and Stephen Balter

8 Coronary and Valvular Intervention Prior to

Noncardiac Surgery, 159

Craig R. Narins

9 Sex and Ethnicity Issues in Interventional

Cardiology, 173

Matthew R. Summers, Sahar Naderi, and Leslie Cho

SECTION II Pharmacologic Intervention, 185

10 Platelet Inhibitor Agents, 189

Matthew J. Price and Dominick J. Angiolillo

11 Anticoagulation in Percutaneous Coronary Intervention, 215 Trent Hartshorne and Derek P. Chew

12 Thrombolytic Intervention, 229

Matthews Chacko and Khalil Ibrahim

13 Other Adjunctive Drugs for Coronary Intervention: Beta-Blockers, Calcium-Channel Blockers, andAngiotensin-Converting Enzyme Inhibitors, 247 David W. Allen and Vivek Rajagopal

SECTION III Coronary Intervention, 257

14 Coronary Stenting: Practical Considerations,Equipment Selection, Tips and Caveats, 261 Elliott M. Groves and Curtiss T. Stinis

15 Coronary Stenting, 275

Tullio Palmerini and Ajay J. Kirtane

16 Bioresorbable Coronary Scaffolds, 329

Athanasios Katsikis, Rodrigo Modolo, Yuki Katagiri, Yoshinobu Onuma, and Patrick W. Serruys

17 Drug-Eluting Balloons, 343

Bruno Scheller

18 Elective Intervention for Stable Angina or Silent Ischemia, 353

Gregory W. Barsness, David E. Kandzari, and Eliano P. Navarese

19 Intervention for Non-ST-Segment Elevation Acute Coronary Syndromes, 373

C. Michael Gibson, Serge Korjian, and Yazan Daaboul

20 Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction, 391

Gjin Ndrepepa, Robert A. Byrne, and Adnan Kastrati

21 Post-Percutaneous Coronary Intervention

Hospitalization, Length of Stay, and Discharge

Planning, 439

Amit N. Vora and Sunil V. Rao

22 Interventions in Cardiogenic Shock, 451

Satya S. Shreenivas, Scott M. Lilly, and Howard C. Herrmann

23 Bifurcations and Branch Vessel Stenting, 461

Antonio Colombo and Goran Stankovic

24 Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Stenosis, 483

Jung-Min Ahn, Duk-Woo Park, and Seung-Jung Park

25 Complex and Multivessel Percutaneous CoronaryIntervention, 493

Sergio Buccheri and Davide Capodanno

26 Intervention for Coronary Chronic TotalOcclusions, 505

Ravi S. Hira and William L. Lombardi

27 Bypass Graft Intervention, 519

John S. Douglas, Jr.

28 The Thrombus-Containing Lesion, 537

On Topaz

29 Complications of Percutaneous Coronary Intervention, 565

Marvin H. Eng, Jeffrey W. Moses, and Paul S. Teirstein

30 Periprocedural Myocardial Infarction and Embolism-Protection Devices, 587

Adrian W. Messerli, Khaled M. Ziada, and Debabrata Mukherjee

31 Access Management and Closure Devices, 613

Fernando Cura and Marcelo Abud

32 Transradial Access for Cardiovascular Catheterization and Intervention, 629